Prognostic Significance of Perinephric Fat Infiltration and Tumor Size in Renal Cell Carcinoma
- 31 August 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 180 (2), 486-491
- https://doi.org/10.1016/j.juro.2008.04.034
Abstract
Purposes: It is controversial that perinephric fat infiltration has an impact on survival in patients with renal cell carcinoma. Therefore, we evaluated the influence of perinephric fat infiltration and tumor size on patient survival. Materials and Methods: We retrospectively reviewed the medical records of 783 and 77 patients with pT1-2 (cN0M0) and pT3a (cN0M0) renal cell carcinoma, respectively. Sporadic unilocular noncystic renal cell carcinoma was included. Univariate and multivariate analyses of prognostic factors, including perinephric fat infiltration, on cancer specific and disease-free survival were performed. Median followup was 56.0 months after surgery. Results: Patients with pT1-2 and pT3a tumors had a 5-year cancer specific survival rate of 96.1% and 84.9%, and a 5-year disease-free survival rate of 93.4% and 74.7%, respectively (each p <0.01). Age, tumor size and Fuhrman nuclear grade were independent prognostic factors for cancer specific and disease-free survival, whereas perinephric fat infiltration was significant only for disease-free survival. However, perinephric fat infiltration had a significant effect on cancer specific survival in patients with pT3a tumors more than 7 cm (p = 0.001). In contrast, patients with pT3a tumors 7 cm or less had cancer specific and disease-free survival similar to that of patients with pT2 tumors. Recurrence of pT3a tumors greater than 7 cm was observed in 44% of patients but in only 14.6% of those with pT3a tumors 7 cm or less (p = 0.029). In contrast to the recurrence of tumors 7 cm or less, recurrence of pT3a tumors more than 7 cm usually developed at multiple sites with a large tumor burden and it progressed rapidly. Consequently 85% of patients with recurrence of pT3a tumors larger than 7 cm died of renal cell carcinoma compared with 33% of those with recurrence of pT3a tumors 7 cm or less (p = 0.001). Conclusions: In pT3a renal cell carcinoma tumor size was the strongest prognostic factor of disease-free and cancer specific survival. Perinephric fat infiltration was an independent prognostic factor for disease-free survival but not for cancer specific survival due to the less aggressive behavior of small (7 cm or less) pT3a tumors after recurrence. Tumor size and perinephric fat infiltration should be included in T3a renal cell carcinoma staging.Keywords
This publication has 15 references indexed in Scilit:
- Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre ExperienceEuropean Urology, 2007
- Does Stage T3a Renal Cell Carcinoma Embrace a Homogeneous Group of Patients?Journal of Urology, 2007
- Impact of Tumor Size on the Predictive Ability of the pT3a Primary Tumor Classification for Renal Cell CarcinomaJournal of Urology, 2007
- Staging refinements in renal cell carcinomaCurrent Opinion in Urology, 2006
- Reevaluation of TNM staging of renal cortical tumors: Recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalentUrology, 2006
- PATHOLOGICAL STAGE DOES NOT ALTER THE PROGNOSIS FOR RENAL LESIONS DETERMINED TO BE STAGE T1 BY COMPUTERIZED TOMOGRAPHYJournal of Urology, 2005
- CURRENT TNM CLASSIFICATION OF RENAL CELL CARCINOMA EVALUATED: REVISING STAGE T3aJournal of Urology, 2005
- Re‐evaluation of the Tumour‐Node‐Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a)BJU International, 2004
- The Heidelberg classification of renal cell tumoursThe Journal of Pathology, 1997
- Disease Outcome in Patients With Low Stage Renal Cell Carcinoma Treated With Nephron Sparing or Radical SurgeryJournal of Urology, 1996